SBE 13 Hydrochloride: A Potent and Selective PLK1 Inhibitor for Cancer Research
Discover the potential of SBE 13 Hydrochloride, a leading PLK1 inhibitor crucial for advancing cancer therapy research and understanding cell cycle regulation.
Get a Quote & SampleProduct Core Value
SBE 13 Hydrochloride
As a trusted supplier in China, we offer SBE 13 Hydrochloride, a highly selective inhibitor targeting the inactive conformation of Polo-like Kinase 1 (PLK1). This compound is pivotal for researchers investigating cancer cell proliferation reduction and cell cycle modulation. Its potent activity and specificity make it an invaluable tool in preclinical oncology drug development.
- Expertly synthesized and validated, SBE 13 Hydrochloride provides potent anti-cancer activity, demonstrating a significant reduction in cancer cell proliferation.
- Facilitate deeper research into G2/M cell cycle arrest, a critical phase in cell division, with the precise action of SBE 13 Hydrochloride.
- Investigate apoptosis induction in cancer models, leveraging SBE 13 Hydrochloride's proven ability to promote programmed cell death in malignant cells.
- Utilize a leading PLK1 inhibitor for preclinical research, contributing to the development of next-generation targeted cancer therapies.
Product Advantages
Targeted Inhibition
SBE 13 Hydrochloride offers exceptional selectivity for PLK1, minimizing off-target effects and ensuring reliable results in your research, particularly in targeting the inactive PLK1 conformation.
Potent Efficacy
With a low IC50 value, this compound effectively inhibits PLK1 activity, crucial for studies focused on cancer cell proliferation reduction and understanding the nuances of targeted therapy.
Therapeutic Potential
Its demonstrated ability to induce G2/M arrest and apoptosis makes SBE 13 Hydrochloride a key compound for exploring novel cancer treatment strategies.
Key Applications
Oncology Drug Development
SBE 13 Hydrochloride is a critical research tool for developing novel cancer therapies, particularly those targeting PLK1. Its role in cancer cell proliferation reduction is extensively studied.
Cell Cycle Research
Investigate the intricate mechanisms of the cell cycle, especially the G2/M phase, using this potent PLK1 inhibitor to understand checkpoints and cell division processes.
Apoptosis Studies
Explore the pathways leading to programmed cell death in cancer cells, a key area where SBE 13 Hydrochloride demonstrates significant efficacy in promoting apoptosis induction.
Biochemical Assays
Utilize SBE 13 Hydrochloride in biochemical assays to precisely measure PLK1 activity and evaluate the effects of inhibition on various cellular functions.